Back to Results
First PageMeta Content



PIPELINE WATCH Rivastigmine and nateglinide show up n many of Europe’s largest markets, supplementary protection certificates (SPCs) for the Alzheimer’s drug rivastigmine – the active ingredient in Novartis’ Exe
Add to Reading List

Document Date: 2011-09-22 20:30:39


Open Document

File Size: 31,31 KB

Share Result on Facebook